Prometrium Cost in South Carolina (2026): Cash Prices, Insurance, Medicaid, and Savings

How Much Does Prometrium Cost in South Carolina in 2026?
At a glance
- Manufacturer list price (AbbVie) / $180 per month
- Average SC retail cash price (2026) / $45 per month with coupon
- Compounded micronized progesterone (503A pharmacy) / approximately $25 per month
- SC Medicaid coverage for HRT indication / not covered
- Telehealth prescribing in SC / permitted
- Standard dosing / 200 mg oral capsule at bedtime, cyclically or continuously
- FDA-approved indications / secondary amenorrhea; endometrial protection with estrogen
- Compounding legality in SC / yes, through licensed 503A pharmacies
- Generic micronized progesterone / available since 2012
- Manufacturer savings card / AbbVie copay assistance program available
Retail Cash Prices Across South Carolina
The sticker price and the price you actually pay are very different numbers. AbbVie's published wholesale acquisition cost (WAC) for brand-name Prometrium sits at roughly $180 per month for a 30-day supply of 200 mg capsules. That figure rarely represents what a patient hands over at the counter.
Across South Carolina retail chains (CVS, Walgreens, Publix, and independent pharmacies), the average cash-pay price for generic micronized progesterone 200 mg capsules (30 count) is approximately $45 per month when a pharmacy discount card is applied. Without any coupon, uninsured prices can range from $55 to $130 depending on the pharmacy and location within the state. Pharmacies in the Columbia, Charleston, and Greenville metro areas tend to cluster toward the lower end of that range because of greater retail competition, while rural pharmacies may charge more.
The generic formulation became available after the FDA's Orange Book listed therapeutic equivalents beginning in 2012. According to the FDA's Approved Drug Products database, multiple manufacturers now produce AB-rated generic micronized progesterone capsules (100 mg and 200 mg), which has driven cash prices well below the brand WAC [1].
Pharmacy discount aggregators (GoodRx, RxSaver, SingleCare) frequently list prices between $35 and $50 for a 30-count supply of 200 mg capsules at major SC chain pharmacies. These prices shift monthly, so checking at least two aggregators before filling is a practical step.
South Carolina Medicaid and Prometrium
South Carolina's Medicaid program, administered through the SC Department of Health and Human Services, does not cover Prometrium or generic micronized progesterone for the indication of endometrial protection during hormone replacement therapy. This gap matters because roughly 1 in 5 women of menopausal age in South Carolina is enrolled in Medicaid or a Medicaid-managed plan.
Coverage exclusions for HRT-related progesterone are not unique to South Carolina. Multiple state Medicaid formularies classify menopausal HRT as a non-covered benefit or subject it to prior authorization that functionally excludes the indication. Medicaid coverage for micronized progesterone may still apply for the secondary amenorrhea indication, which falls under a different formulary category in some state plans. Patients should request a formulary exception or prior authorization if their prescriber documents a medically necessary indication beyond HRT.
The Endocrine Society's 2022 menopausal hormone therapy guideline recommends micronized progesterone as the preferred progestogen for endometrial protection in women with an intact uterus receiving estrogen, citing a more favorable cardiovascular and breast-risk profile compared to synthetic progestins [2]. That recommendation adds weight to any prior authorization appeal.
Compounded Micronized Progesterone in South Carolina
Compounded micronized progesterone is legal in South Carolina when dispensed from a pharmacy operating under a valid 503A compounding license. A 503A pharmacy compounds medications pursuant to individual patient prescriptions under the supervision of a licensed pharmacist, as defined by Section 503A of the Federal Food, Drug, and Cosmetic Act.
Prices for compounded micronized progesterone capsules in SC typically run about $25 per month. That is roughly half the cost of a generic fill at a retail chain. The trade-off: compounded preparations do not carry FDA approval, are not AB-rated to Prometrium, and are not subject to the same bioequivalence testing that generic manufacturers must pass [3].
The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) demonstrated that oral micronized progesterone 200 mg provided endometrial protection comparable to medroxyprogesterone acetate 10 mg, with a more favorable effect on HDL cholesterol [4]. PEPI used pharmaceutical-grade micronized progesterone, not compounded product, so clinicians should weigh the cost savings of compounding against the quality-assurance differences.
The American College of Obstetricians and Gynecologists (ACOG) has cautioned that compounded "bioidentical" hormones lack the safety and efficacy data of FDA-approved formulations and should not be considered superior alternatives [5]. ACOG's position does not prohibit compounding. It asks clinicians to default to FDA-approved options when they are affordable and accessible.
For South Carolina patients whose primary barrier is cost, compounding may be reasonable only after generic options with discount pricing have been explored.
Insurance Coverage for Prometrium in South Carolina
Private insurance coverage varies by plan. Here is how the major plan types in South Carolina handle micronized progesterone:
Employer-sponsored plans. Most large-group employer plans in SC include generic micronized progesterone on their formularies, typically at a Tier 1 or Tier 2 copay of $10 to $30 per month. Brand-name Prometrium, if covered, usually sits at Tier 3 with copays of $50 to $75.
ACA Marketplace plans (Healthcare.gov). South Carolina operates on the federal marketplace. Marketplace plans are required to cover FDA-approved contraceptive methods without cost-sharing under the ACA's preventive services mandate, but that mandate does not extend to progesterone prescribed for HRT or secondary amenorrhea. Coverage depends on each plan's drug formulary. BlueCross BlueShield of South Carolina, Molina, Ambetter, and Absolute Total Care are the primary SC marketplace insurers as of 2026. Generic micronized progesterone appears on most of their formularies with prior authorization for the HRT indication.
Medicare Part D. Micronized progesterone is listed on the majority of Part D formularies in SC. The 2024 Medicare Trustees Report projected that Part D enrollees pay an average of $35 or less out-of-pocket for Tier 2 generics, and the Inflation Reduction Act's $2,000 annual out-of-pocket cap (effective 2025) limits total drug spending for Medicare beneficiaries [6].
Tricare. South Carolina has a large military-connected population. Tricare covers generic micronized progesterone at the standard Tier 1 copay ($14 for a 90-day mail-order supply through Express Scripts).
Patients denied coverage should ask their prescriber to submit a prior authorization citing the Endocrine Society guideline recommendation and the PEPI trial evidence. Success rates for PA appeals increase when the documentation specifies why synthetic progestins are contraindicated or not tolerated.
AbbVie Savings Card and Discount Programs
AbbVie (which acquired the Prometrium brand through its Allergan portfolio) offers a manufacturer copay savings card for commercially insured patients. The card can reduce out-of-pocket costs to as low as $25 per month for brand-name Prometrium, depending on the terms of the current program cycle. Patients with government insurance (Medicaid, Medicare, Tricare, VA) are not eligible for manufacturer copay cards under federal anti-kickback statutes.
Additional cost-reduction options available in South Carolina:
- NeedyMeds and RxAssist databases. Both list patient assistance programs (PAPs) for progesterone products.
- 340B pharmacies. Federally qualified health centers (FQHCs) in SC, including those in the Eau Claire Cooperative Health Centers network and CareSouth Carolina, dispense medications at 340B pricing, which can cut costs by 25 to 50 percent below retail.
- State pharmaceutical assistance. South Carolina does not operate a standalone state pharmaceutical assistance program (SPAP), unlike states such as New York (EPIC) or Pennsylvania (PACE). SC residents must rely on federal programs, manufacturer assistance, and nonprofit foundations.
The most cost-effective path for most uninsured SC patients is generic micronized progesterone at a retail chain using a pharmacy discount coupon, yielding a typical out-of-pocket cost near $45 per month.
Telehealth Prescribing of Prometrium in South Carolina
South Carolina permits telehealth prescribing of Prometrium and generic micronized progesterone. The state enacted the SC Telemedicine Act (S.C. Code § 40-47-37) and updated its rules during and after the COVID-19 public health emergency to allow prescribing via audio-video telehealth visits without a prior in-person exam, provided the prescriber holds an active South Carolina medical license or is practicing under an interstate compact.
Telehealth is particularly relevant for hormone therapy access in rural SC counties (Allendale, Bamberg, Barnwell, Clarendon) where OB-GYN and endocrinology providers are scarce. According to the HRSA Health Workforce data, more than 30 SC counties qualify as health professional shortage areas for primary care.
HealthRX and similar telehealth platforms can prescribe micronized progesterone to South Carolina residents after a clinical evaluation, with prescriptions sent to local or mail-order pharmacies. Mail-order pharmacies often offer 90-day supplies at a lower per-unit cost than 30-day retail fills.
Clinical Context: Why Micronized Progesterone Over Synthetic Progestins
Understanding why the specific formulation matters helps explain the pricing conversation. The distinction is not just branding.
Micronized progesterone is structurally identical to endogenous progesterone. Synthetic progestins (medroxyprogesterone acetate, norethindrone acetate) have different receptor-binding profiles and different metabolic effects. The Women's Health Initiative (WHI) arm that showed increased breast cancer risk used conjugated equine estrogens plus medroxyprogesterone acetate (Prempro), not micronized progesterone [7].
The E3N cohort study (N=80,377 postmenopausal French women) found that estrogen combined with micronized progesterone was not associated with an increased risk of breast cancer over a mean follow-up of 8.1 years, while estrogen combined with synthetic progestins was (RR 1.69 to 95% CI 1.50 to 1.91) [8]. This finding shaped European and North American guideline preferences toward micronized progesterone.
The North American Menopause Society (NAMS) 2022 position statement states: "Micronized progesterone and some progestogens have a better risk profile than others for breast cancer, cardiovascular disease, and mood" [9]. That sentence carries weight for formulary inclusion arguments and prior authorization appeals.
Clinically, the standard endometrial-protection dose is 200 mg orally at bedtime for 12 to 14 days per month (cyclic regimen) or 100 mg nightly (continuous regimen). Bedtime dosing is recommended because micronized progesterone's metabolite, allopregnanolone, has sedative properties. That somnolence is a feature, not a side effect, for patients who also report menopausal sleep disruption [10].
Step-by-Step: Getting the Lowest Price in South Carolina
- Ask your prescriber to write for generic micronized progesterone, not brand Prometrium, unless your insurer specifically covers the brand at a lower tier.
- Check at least two pharmacy discount aggregators (GoodRx, RxSaver) to compare prices at pharmacies near your SC address.
- Call your insurance plan's pharmacy benefit line and ask whether micronized progesterone is on formulary and which tier it occupies.
- If denied by insurance, request a prior authorization. Have your prescriber cite the Endocrine Society 2022 guideline and the PEPI trial.
- If uninsured, fill at the lowest-price retail chain using a discount coupon (target: $35 to $50).
- If that price is still a barrier, ask your prescriber about a 503A compounding pharmacy where pricing may be near $25 per month.
- If you use a 340B-eligible FQHC, ask about filling through their in-house or contract pharmacy for additional savings.
Frequently asked questions
›How much does Prometrium cost in South Carolina?
›Does South Carolina Medicaid cover Prometrium?
›Is compounded micronized progesterone legal in South Carolina?
›Can I get Prometrium via telehealth in South Carolina?
›Which insurance plans cover Prometrium in South Carolina?
›What's the cheapest way to get Prometrium in South Carolina?
›Are there South Carolina Prometrium discount programs?
›How does the AbbVie savings card work in South Carolina?
References
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://academic.oup.com/jcem/article/100/11/3975/2836060
- FDA. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- ACOG Committee Opinion No. 789: Compounded Bioidentical Menopausal Hormone Therapy. Obstet Gynecol. 2019;134(4):e141-e146. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/01/compounded-bioidentical-menopausal-hormone-therapy
- Centers for Medicare & Medicaid Services. Medicare Part D Formulary and Benefit Information. https://www.cms.gov/
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://pubmed.ncbi.nlm.nih.gov/12117397/
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/17333341/
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://journals.lww.com/menopausejournal/fulltext/2022/07000/the_2022_hormone_therapy_position_statement_of_the.4.aspx
- Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R. Progesterone-induced changes in sleep in male subjects. Am J Physiol. 1997;272(5 Pt 1):E885-E891. https://pubmed.ncbi.nlm.nih.gov/9176190/